Brain Morphology Analysis
Brain Morphology Analysis - Related Videos
11:48
Analysis of Dendritic Spine Morphology in Cultured CNS Neurons
0 Views •
Cited by 69 •
2011
Numerous recent studies have identified mutations in synaptic proteins associated with brain pathologies. Primary cultured cortical neurons offer great flexibility in examining the effects of these disease-associated proteins on dendritic spine morphology and motility.
03:54
Preparation of Bacterial Biofilm Colonies for Morphological Analysis
0 Views •
2026
Source: Bucher, T., et. al., Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors. J. Vis. Exp.(2016)This video demonstrates the preparation of mature bacterial biofilm colonies for high-resolution imaging. It covers fixation, dehydration, mounting, and metal coating steps to preserve and visualize biofilm morphology.
06:42
Cerebrovascular Casting of the Adult Mouse for 3D Imaging and Morphological Analysis
0 Views •
Cited by 29 •
2011
In this article, we present a simple, practical technique for cerebrovascular casting that is easy to perform and can be utilized to image the vascular tree of the adult mouse brain.
07:59
The Analysis of Purkinje Cell Dendritic Morphology in Organotypic Slice Cultures
0 Views •
Cited by 15 •
2012
We present a protocol that permits to view and to quantitatively asses the morphology of the dendritic tree of individual Purkinje cells grown in organotypic cerebellar slice cultures. This protocol is intended to promote studies on the mechanisms of Purkinje cell dendritic development.
11:41
Automated Sholl Analysis of Digitized Neuronal Morphology at Multiple Scales
0 Views •
Cited by 61 •
2010
We have developed a computer program to analyze neuronal morphology. In combination with two existing open source analysis tools, our program performs Sholl analysis and determines the number of neurites, branch points, and neurite tips. The analyses are performed so that local changes in neurite morphology can be observed.
FAQs
Segmentation separates brain regions and tissues in neuroimaging data, while spatial alignment places measurements into a comparable anatomical framework. Together, these computational steps allow researchers to quantify regional volume, cortical thickness, shape, and organization more consistently. This supports detection of structural differences that may be associated with drug exposure or treatment response.
Regional volume and cortical thickness provide different structural readouts. Regional volume describes the amount of tissue in a selected area, whereas cortical thickness focuses on the thickness of cortical tissue. Shape and organization add further anatomical information. Considering these measures together can help characterize how drug exposure or treatment relates to structural differences across brain regions.
Structural measurements become more informative when interpreted with behavioral or functional outcomes. A regional volume or cortical-thickness difference identifies an anatomical change, while behavioral or functional data help relate that change to consequences of treatment. In pharmacology, this combined view can support interpretation of drug effects and connect measurable anatomy with therapeutic efficacy or possible harm.
A typical workflow begins with neuroimaging data, followed by image segmentation to separate relevant regions or tissues. Spatial alignment then supports anatomical comparison, after which researchers measure regional volume, cortical thickness, shape, or organization. The resulting quantitative markers can be examined in relation to treatment exposure and behavioral or functional outcomes.
Researchers may apply Brain Morphology Analysis when studying whether a drug affects brain development, degeneration, toxicity, or recovery. The approach is useful in both preclinical studies and clinical research because it supplies quantitative markers of structural effects. These measurements can then support evaluations of treatment safety and efficacy in the relevant pharmacological setting.
Quantitative morphological findings can indicate whether a treatment is associated with structural change or recovery in brain regions. When paired with exposure data and behavioral or functional outcomes, they provide a framework for interpreting therapeutic effects and potential toxicity. This makes the approach relevant to judging both efficacy and safety across preclinical and clinical research.